Adjunctive electroacupuncture to facilitate discontinuation of non-benzodiazepine hypnotics in chronic insomnia: a randomized controlled trial protocol - Top-Institutions - MDSpire

Adjunctive electroacupuncture to facilitate discontinuation of non-benzodiazepine hypnotics in chronic insomnia: a randomized controlled trial protocol

  • By

  • Yaoxin Chen

  • Pei Shen

  • Gongyue Zhou

  • Wenlin Xu

  • Yijia Wan

  • Cong Wang

  • May 6, 2026

  • 0 min

Share

Top Institutions in Psychiatry

Brief introduction explaining scope and methodology.

  • #1

    Zhejiang Provincial Hospital of Traditional Chinese Medicine
    Zhejiang Provincial Hospital of Traditional Chinese Medicine

    Hangzhou, Zhejiang

    Key Differentiators

    • Traditional Chinese Medicine
    • Acupuncture

  • #2

    First Affiliated Hospital of Henan University of Chinese Medicine
    First Affiliated Hospital of Henan University of Chinese Medicine

    Zhengzhou, Henan

    Key Differentiators

    • Traditional Chinese Medicine
    • Sleep Medicine

  • #3

    Second Affiliated Hospital of Anhui Medical University
    Second Affiliated Hospital of Anhui Medical University

    Hefei, Anhui

    Key Differentiators

    • Medical Research
    • Ethics

  • #4

    American Academy of Sleep Medicine
    American Academy of Sleep Medicine

    Darien, Illinois

    Key Differentiators

    • Sleep Medicine
    • Clinical Guidelines

Original Source(s)

Adjunctive electroacupuncture to facilitate discontinuation of non-benzodiazepine hypnotics in chronic insomnia: a randomized controlled trial protocol

  • by Yaoxin Chen, Pei Shen, Gongyue Zhou, Wenlin Xu, Yijia Wan, Cong Wang

  • May 6, 2026

Related Content

Top 10 States With Rising Demand for Physicians

These 10 states report physician shortages, projected physician supply gaps, or physician-to-population ratios below national benchmarks.

Seasonal and gender-specific patterns in prescriptions for hypnotic and sedative medications in primary care

GLP-1 Drugs Tied to Lower Addiction Risk

In a target-trial emulation of more than 600,000 veterans, GLP-1 RA initiators saw fewer new substance use disorders—and patients with existing SUDs had fewer overdoses, hospitalizations, and deaths.